Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Sirolimus

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00392951Phase 1/2Completed

Sirolimus for Autoimmune Disease of Blood Cells

Showing all 1 trials

Research Network

Common Treatments

  • Sirolimus1

Active Sponsors

  • Children's Hospital of Philadelphia1

Top Investigators

Related Conditions

  • Anemia Hemolytic Autoimmune1
  • Autoimmune Neutropenia1
  • Evans Syndrome1
  • Idiopathic Thrombocytopenic Purpura1
  • Lupus Erythematosus Systemic1

Activity Timeline